PROTAC Cell Permeability and Oral Bioavailability: A Journey Into Uncharted Territory

可药性 图书馆学 医学 化学 万维网 计算机科学 生物化学 基因
作者
Vasanthanathan Poongavanam,Jan O. Kihlberg
出处
期刊:Future Medicinal Chemistry [Future Science Ltd]
卷期号:14 (3): 123-126 被引量:75
标识
DOI:10.4155/fmc-2021-0208
摘要

Future Medicinal ChemistryVol. 14, No. 3 EditorialPROTAC cell permeability and oral bioavailability: a journey into uncharted territoryVasanthanathan Poongavanam & Jan KihlbergVasanthanathan Poongavanam https://orcid.org/0000-0002-8880-9247Department of Chemistry - BMC, Uppsala University, SE-75123, Uppsala, SwedenSearch for more papers by this author & Jan Kihlberg *Author for correspondence: E-mail Address: jan.kihlberg@kemi.uu.sehttps://orcid.org/0000-0002-4205-6040Department of Chemistry - BMC, Uppsala University, SE-75123, Uppsala, SwedenSearch for more papers by this authorPublished Online:29 Sep 2021https://doi.org/10.4155/fmc-2021-0208AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInReddit View articleKeywords: ADME/Toxdrug designin vitro assaysmolecular chameleonoral druggable spaceReferences1. Edmondson SD, Yang B, Fallan C. Proteolysis targeting chimeras (PROTACs) in ‘beyond rule-of-five’ chemical space: recent progress and future challenges. Bioorg. Med. Chem. Lett. 29, 1555–1564 (2019).Crossref, Medline, CAS, Google Scholar2. Maple HJ, Clayden N, Baron A, Stacey C, Felix R. Developing degraders: principles and perspectives on design and chemical space. Med. Chem. Commun. 10, 1755–1764 (2019).Crossref, CAS, Google Scholar3. Doak BC, Over B, Giordanetto F, Kihlberg J. Oral druggable space beyond the rule of 5: insights from drugs and clinical candidates. Chem. Biol. 21, 1115–1142 (2014).Crossref, Medline, CAS, Google Scholar4. DeGoey DA, Chen H-J, Cox PB, Wendt MD. Beyond the rule of 5: lessons learned from AbbVie's drugs and compound collection. J. Med. Chem. 61, 2636–2651 (2018).Crossref, Medline, CAS, Google Scholar5. Wishart DS, Feunang YD, Guo AC et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 46, D1074–D1082 (2018).Crossref, Medline, CAS, Google Scholar6. Weng G, Shen C, Cao D et al. PROTAC-DB: an online database of PROTACs. Nucleic Acids Res. 49(D1), D1381–D1387 (2021).Crossref, Medline, CAS, Google Scholar7. Atilaw Y, Poongavanam V, Svensson Nilsson C et al. Solution conformations shed light on PROTAC cell permeability. ACS Med. Chem. Lett. 12, 107–114 (2021).Crossref, Medline, CAS, Google Scholar8. Danelius E, Poongavanam V, Peintner S, Wieske LHE, Erdélyi M, Kihlberg J. Solution conformations explain the chameleonic behavior of macrocyclic drugs. Chem. Eur. J. 26(23), 5231–5244 (2020).Crossref, Medline, CAS, Google Scholar9. Klein VG, Townsend CE, Testa A et al. Understanding and improving the membrane permeability of VH032-based PROTACs. ACS Med. Chem. Lett. 11(9), 1732–1738 (2020).Crossref, Medline, CAS, Google Scholar10. Pike A, Williamson B, Harlfinger S, Martin S, McGinnity DF. Optimising proteolysis-targeting chimeras (PROTACs) for oral drug delivery: a drug metabolism and pharmacokinetics perspective. Drug Discov. Today 25, 1793-1800 (2020).Crossref, Medline, CAS, Google Scholar11. Cantrill C, Chaturvedi P, Rynn C, Schaffland JP, Walter I, Wittwer MB. Fundamental aspects of DMPK optimization of targeted protein degraders. Drug Discov. Today 25, 969–982 (2020).Crossref, Medline, CAS, Google Scholar12. Ermondi G, Vallaro M, Caron G. Degraders early developability assessment: face-to-face with molecular properties. Drug Discov. Today 25(9), 1585–1591 (2020).Crossref, Medline, CAS, Google Scholar13. Scott DE, Rooney TPC, Bayle ED et al. Systematic investigation of the permeability of androgen receptor PROTACs. ACS Med. Chem. Lett. 11, 1539–1547 (2020).Crossref, Medline, CAS, Google Scholar14. Halford B. Arvinas unveils PROTAC structures. Chem. Eng. News 99(14), magazine/99/09914 (2021).Google Scholar15. Sun X, Wang J, Yao X et al. A chemical approach for global protein knockdown from mice to non-human primates. Cell Discov. 5, 10 (2019).Crossref, Medline, Google Scholar16. Tinworth CP, Lithgow H, Dittus L et al. PROTAC-mediated degradation of Bruton's tyrosine kinase is inhibited by covalent binding. ACS Chem. Biol. 14, 342–347 (2019).Crossref, Medline, CAS, Google Scholar17. Poongavanam V, Danelius E, Peintner S et al. Conformational sampling of macrocyclic drugs in different environments – can we find the relevant conformations? ACS Omega 3, 11742–11757 (2018).Crossref, Medline, CAS, Google Scholar18. Poongavanam V, Atilaw Y, Ye S et al. Predicting the permeability of macrocycles from conformational sampling – limitations of molecular flexibility. J. Pharm. Sci. 110, 301–313 (2021).Crossref, Medline, CAS, Google Scholar19. Goracci L, Desantis J, Valeri A, Castellani B, Eleuteri M, Cruciani G. Understanding the metabolism of proteolysis targeting chimeras (PROTACs): the next step toward pharmaceutical applications. J. Med. Chem. 63, 11615–11638 (2020).Crossref, Medline, CAS, Google Scholar20. Bemis TA, La Clair JJ, Burkart MD. Unraveling the role of linker design in proteolysis targeting chimeras. J. Med. Chem. 64, 8042–8052 (2021).Crossref, Medline, CAS, Google ScholarFiguresReferencesRelatedDetailsCited ByDesign, synthesis and bioactivity evaluation of self-assembled PROTACs based on multi-target kinase inhibitorsBioorganic Chemistry, Vol. 134Trends in Molecular Properties, Bioavailability, and Permeability across the Bayer Compound Collection8 February 2023 | Journal of Medicinal Chemistry, Vol. 66, No. 4Predictive Modeling of PROTAC Cell Permeability with Machine Learning1 February 2023 | ACS Omega, Vol. 8, No. 6Natural product-based PROteolysis TArgeting Chimeras (PROTACs)1 January 2022 | Natural Product Reports, Vol. 39, No. 12Linker-Dependent Folding Rationalizes PROTAC Cell Permeability28 September 2022 | Journal of Medicinal Chemistry, Vol. 65, No. 19Strategies for the discovery of oral PROTAC degraders aimed at cancer therapyCell Reports Physical Science, Vol. 3, No. 10The current state of the art and future trends in RAS-targeted cancer therapies26 August 2022 | Nature Reviews Clinical Oncology, Vol. 19, No. 10PROTACs: Current Trends in Protein Degradation by Proteolysis-Targeting Chimeras13 September 2022 | BioDrugs, Vol. 36, No. 5Non-small molecule PROTACs (NSM-PROTACs): Protein degradation kaleidoscopeActa Pharmaceutica Sinica B, Vol. 12, No. 7PROTAC targeted protein degraders: the past is prologue18 January 2022 | Nature Reviews Drug Discovery, Vol. 21, No. 3Hearing loss drug discovery and medicinal chemistry: Current status, challenges, and opportunities Vol. 14, No. 3 Follow us on social media for the latest updates Metrics Downloaded 1,804 times History Received 17 July 2021 Accepted 1 September 2021 Published online 29 September 2021 Published in print February 2022 Information© 2021 Newlands PressKeywordsADME/Toxdrug designin vitro assaysmolecular chameleonoral druggable spaceFinancial & competing interests disclosureThe authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending or royalties.No writing assistance was utilized in the production of this manuscript.PDF download
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
2秒前
珍妮完成签到,获得积分10
2秒前
天涯是我完成签到,获得积分10
2秒前
ding的应助被牧百川采纳,获得10
3秒前
lzq完成签到,获得积分10
3秒前
成就嚓茶完成签到,获得积分10
3秒前
4秒前
李健的应助被徐枘采纳,获得10
4秒前
酷波er的应助被LL采纳,获得10
4秒前
吃土豆块不吃土豆条完成签到,获得积分10
5秒前
幸运小yu完成签到 ,获得积分10
5秒前
7秒前
7秒前
TaoJ的应助被angelsu采纳,获得10
7秒前
今后的应助被念安采纳,获得20
8秒前
赘婿的应助被阿吉采纳,获得10
9秒前
FashionBoy的应助被自由笙采纳,获得10
9秒前
9秒前
白江虎发布了新的文献求助10
9秒前
9秒前
隐形曼青的应助被小SCI采纳,获得10
10秒前
风吹麦浪的应助被elysia采纳,获得10
10秒前
11秒前
大模型的应助被季喃采纳,获得10
11秒前
momo完成签到,获得积分10
11秒前
12秒前
12秒前
12秒前
大粥完成签到 ,获得积分10
13秒前
13秒前
13秒前
gamerks发布了新的文献求助10
14秒前
14秒前
lli发布了新的文献求助30
14秒前
庚辛完成签到,获得积分10
15秒前
15秒前
xc完成签到,获得积分10
15秒前
16秒前
爱科研的赛关注了科研通微信公众号
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183730
求助须知:如何正确求助?哪些是违规求助? 9572975
关于积分的说明 21828453
捐赠科研通 7780887
什么是DOI,文献DOI怎么找? 3434086
关于科研通互助平台的介绍 2558276
邀请新用户注册赠送积分活动 2480557